Clinical Trial Update: MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806 [NA]

View source ↗

Summary

A clinical trial evaluating the brain effects of efaproxiral in patients with recurrent or progressive glioma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Efaproxiral (efaproxiral)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | NA | Status: WITHDRAWN